148 related articles for article (PubMed ID: 31465596)
1. Ablative fractional laser-assisted photodynamic therapy for lentigo maligna: a prospective pilot study.
Räsänen JE; Neittaanmäki N; Jeskanen L; Pölönen I; Snellman E; Grönroos M
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):510-517. PubMed ID: 31465596
[TBL] [Abstract][Full Text] [Related]
2. Immunocryosurgery as monotherapy for lentigo maligna or combined with surgical excision for lentigo maligna melanoma.
Matas-Nadal C; Sòria X; García-de-la-Fuente MR; Huerva V; Ortega E; Vilardell F; Gatius S; Casanova JM; Martí RM
J Dermatol; 2018 May; 45(5):564-570. PubMed ID: 29430695
[TBL] [Abstract][Full Text] [Related]
3. Ablative fractional laser-assisted photodynamic therapy provides superior long-term efficacy compared with standard methyl aminolevulinate photodynamic therapy for lower extremity Bowen disease.
Kim HJ; Song KH
J Am Acad Dermatol; 2018 Nov; 79(5):860-868. PubMed ID: 29857012
[TBL] [Abstract][Full Text] [Related]
4. Lentigo maligna and intensified ablative fractional laser-assisted PDT: a promising, minimally invasive treatment approach.
Marini L; Marini S
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):440-441. PubMed ID: 32112614
[No Abstract] [Full Text] [Related]
5. A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up.
Ko DY; Kim KH; Song KH
Br J Dermatol; 2014 Jan; 170(1):165-72. PubMed ID: 24102369
[TBL] [Abstract][Full Text] [Related]
6. Effect of Methyl Aminolevulinate Photodynamic Therapy With and Without Ablative Fractional Laser Treatment in Patients With Microinvasive Squamous Cell Carcinoma: A Randomized Clinical Trial.
Choi SH; Kim KH; Song KH
JAMA Dermatol; 2017 Mar; 153(3):289-295. PubMed ID: 28199463
[TBL] [Abstract][Full Text] [Related]
7. [Lentigo maligna and lentigo maligna melanoma: a clinicopathologic analysis of twenty-four cases].
Ren M; Kong YY; Shen XX; Cai X; Kong JC
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):769-774. PubMed ID: 30317732
[No Abstract] [Full Text] [Related]
8. A novel two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod.
de Vries K; Rellum R; Habets JM; Prens EP
Br J Dermatol; 2013 Jun; 168(6):1362-4. PubMed ID: 23252724
[No Abstract] [Full Text] [Related]
9. Lentigo maligna and lentigo maligna melanoma.
Cohen LM
J Am Acad Dermatol; 1995 Dec; 33(6):923-36; quiz 937-40. PubMed ID: 7490362
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ablative fractional laser-assisted photodynamic therapy for the treatment of actinic cheilitis: 12-month follow-up results of a prospective, randomized, comparative trial.
Choi SH; Kim KH; Song KH
Br J Dermatol; 2015 Jul; 173(1):184-91. PubMed ID: 25400009
[TBL] [Abstract][Full Text] [Related]
11. Treatment of lentigo maligna.
Gaspar ZS; Dawber RP
Australas J Dermatol; 1997 Feb; 38(1):1-6; quiz 7-8. PubMed ID: 9046644
[TBL] [Abstract][Full Text] [Related]
12. Er:YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial.
Choi SH; Kim KH; Song KH
J Eur Acad Dermatol Venereol; 2016 May; 30(5):783-8. PubMed ID: 26551044
[TBL] [Abstract][Full Text] [Related]
13. Grenz ray treatment of lentigo maligna and early lentigo maligna melanoma.
Hedblad MA; Mallbris L
J Am Acad Dermatol; 2012 Jul; 67(1):60-8. PubMed ID: 22030019
[TBL] [Abstract][Full Text] [Related]
14. A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose.
Greveling K; de Vries K; van Doorn MB; Prens EP
Br J Dermatol; 2016 May; 174(5):1134-6. PubMed ID: 26615810
[No Abstract] [Full Text] [Related]
15. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma.
Malhotra R; Chen C; Huilgol SC; Hill DC; Selva D
Ophthalmology; 2003 Oct; 110(10):2011-8. PubMed ID: 14522781
[TBL] [Abstract][Full Text] [Related]
16. Laser-assisted photodynamic therapy for superficial basal cell carcinoma and Bowen's disease: a randomized intrapatient comparison between a continuous and a fractional ablative CO
Genouw E; Verheire B; Ongenae K; De Schepper S; Creytens D; Verhaeghe E; Boone B
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1897-1905. PubMed ID: 29633367
[TBL] [Abstract][Full Text] [Related]
17. A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.
Tio D; van der Woude J; Prinsen CAC; Jansma EP; Hoekzema R; van Montfrans C
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):616-624. PubMed ID: 27987308
[TBL] [Abstract][Full Text] [Related]
18. [Lentigo maligna: a special melanoma].
Le Gal FA; Toutous-Trellu L; Kaya G; Salomon D
Rev Med Suisse; 2011 Apr; 7(289):765-6, 768-71. PubMed ID: 21568099
[TBL] [Abstract][Full Text] [Related]
19. Survey of U.K. current practice in the treatment of lentigo maligna.
Mahendran RM; Newton-Bishop JA
Br J Dermatol; 2001 Jan; 144(1):71-6. PubMed ID: 11167685
[TBL] [Abstract][Full Text] [Related]
20. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision.
Huilgol SC; Selva D; Chen C; Hill DC; James CL; Gramp A; Malhotra R
Arch Dermatol; 2004 Sep; 140(9):1087-92. PubMed ID: 15381549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
